SCHEMBL2078872

SCHEMBL2078872

CN(Cc1ccccn1)S(=O)(=O)c1cc(-c2ccnn2-c2ccccc2Cl)c(O)cc1O

nearest known ligand 0.60

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 7/20 0.60
NR3C2 P08235 1/20 0.38
SLC16A3 O15427 1/20 0.37
SLC16A1 P53985 1/20 0.37
PDK1 Q15118 1/20 0.37
HSD17B10 Q99714 1/20 0.37
LMNA P02545 1/20 0.36
PKM P14618 1/20 0.36
SLC12A2 P55011 1/20 0.36
SLC12A5 Q9H2X9 1/20 0.36
CCR6 P51684 1/20 0.36
ALDH1A1 P00352 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NOX4 Q9NPH5 1/20 0.34
ATM Q13315 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL945051 0.90 HSP90AA1 (0.51) HSP90AA1NR3C2SLC16A3SLC16A1ALDH1A1
SCHEMBL2079380 0.90 HSP90AA1 (0.50) HSP90AA1NR3C2HSD17B10KMT2A
SCHEMBL2078746 0.89 HSP90AA1 (0.49) HSP90AA1NR3C2SLC16A3SLC16A1
SCHEMBL1219625 0.89 HSP90AA1 (0.51) HSP90AA1NR3C2HSD17B10SMN1; SMN2KMT2A
SCHEMBL1216341 0.88 HSP90AA1 (0.48) HSP90AA1NR3C2LMNAALDH1A1KMT2A
SCHEMBL1217338 0.88 HSP90AA1 (0.51) HSP90AA1NR3C2SLC16A3SLC16A1ALDH1A1
SCHEMBL1218005 0.88 HSP90AA1 (0.47) HSP90AA1NR3C2SLC16A3SLC16A1PKM
SCHEMBL1629206 0.87 HSP90AA1 (0.51) HSP90AA1NR3C2SLC16A3SLC16A1
SCHEMBL2079472 0.86 HSP90AA1 (0.47) HSP90AA1NR3C2PDK1ALDH1A1NOX4
SCHEMBL1218861 0.85 HSP90AA1 (0.46) HSP90AA1NR3C2ALDH1A1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7906657-B2 1,5-diphenylpyrazoles II as HSP90 inhibitors MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 2011-03-15 US claimed
US-20090325974-A1 1,5-DIPHENYLPYRAZOLES II AS HSP90 INHIBITORS MERCK PATENT GESELLSCHAFT (DE) 2009-12-31 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090325974-A1 1,5-DIPHENYLPYRAZOLES II AS HSP90 INHIBITORS HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885NR3C2 570/4885SLC16A3 4616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.